Press Release Apr 16 2025

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 16, 2025, titled "Glenmark Pharmaceuticals Inc., USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 10 mg, 15 mg, 20 mg and 30 mg".

View Attachment